Diligence memo · auto-generated · as of July 2, 2026

New View Surgical, Inc.

New View Surgical, Inc. looks fair against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

New View Surgical, Inc. operates in Medical Devices, based in Andover.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

New View Surgical, Inc. has raised $16M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $7.0M on 2022-09-15.

Most recent recorded round closed around 2022-09-15.

Valuation (modeled)modeled

Provath models New View Surgical, Inc. at approximately $71M (range $8.6M–$232M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.23× the median modeled value of Series A Medical Devices companies in 2022–2024 (13 peers) — value vs value, same stage and era. Within the normal band (123% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 20 months.

Last raise 3.8 yr ago; this sector typically re-raises about every 16 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 1.2× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 85% of Medical Devices peers (233 compared).

Modeled value ranks above 82% of those peers.

Closest niche peers: MBio Diagnostics, Inc., Vida Diagnostics Inc, Thunder Road Surgical, Llc, Barsa Surgical Inc., Caire Health Holdings, Inc..

Peoplefiled

8 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.